Objectives:

1. Understand currently available medication for the treatment of sickle cell
2. Learning Objective 2:Understand the role Endari has in the treatment of sickle cell
3. Learning Objective 3:Understand the short comings of Endari
4. Can icosapent ethyl reduce CV Risk in patients with hypertriglyceridemia?
5. Learning Objective 2:Does icosapent ehthyl have additive benefit to statins in patients with DM or CV ds and hypertriglyceridemia.
6. Learning Objective 3:Critical review of randomized trial